Rho Capital Partners, Inc.

Latest statistics and disclosures from RHO CAPITAL PARTNERS's latest quarterly 13F-HR filing:

RHO CAPITAL PARTNERS portfolio companies for March 2017 quarter

Company (Ticker) Portfolio Weight Share Count Price Last Trade
Cara Therapeutics 92.21 3.57M +16.00% 18.39 0.00
Inotek Pharmaceuticals 7.39 2.63M 2.00 0.00
Senseonics Hldgs 0.40 159601 -24.00% 1.79 0.00

Past 13F-HR SEC Filings for RHO CAPITAL PARTNERS